Sudeep Pharma IPO Sees Strong Day-2 Demand as GMP Hints at 20% Listing Premium

Sudeep Pharma’s IPO sees strong Day-2 demand with a GMP implying nearly 20% listing gains, backed by robust anchor participation and expansion plans.